Evidence map›Paper›PMID 28157696›Full record

ArticleOncotarget2017

Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells.

Sanjay Kumar, Erdal Eroglu, James A Stokes, Karyn Scissum-Gunn, Sabita N Saldanha, Udai P Singh, Upender Manne, Selvarangan Ponnazhagan, Manoj K Mishra

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Sanjay KumarCancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA.
Erdal ErogluFaculty of Engineering, Bioengineering Department, Celal Bayar University, Muradiye, Manisa, Turkey.
James A StokesCancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA.
Karyn Scissum-GunnCancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA.
Sabita N SaldanhaCancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA.
Udai P SinghDepartment of Pathology, Microbiology and Immunology, University of South Carolina, Columbia, SC, USA.
Upender ManneDepartment of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Selvarangan PonnazhaganDepartment of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Manoj K MishraCancer Biology Research and Training, Department of Biological Sciences, Alabama State University, Montgomery, AL, USA.
Alabama State University · USUniversity of Alabama at Birmingham · USManisa Celal Bayar University · TRUniversity of South Carolina · US

Funding

Training and Education ProgramP20CA192973 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MANNE, UPENDER · 2014 to 2017
$767k
Project 2: 2/2 The Alabama State University/UAB Comprehensive Cancer Center PartnershipP20CA192976 · NCI · ALABAMA STATE UNIVERSITY · PI MISHRA, MANOJ K. · 2014 to 2017
$598k
NCI NIH HHS P20 CA192973NCI NIH HHS P20 CA192976
6 · The paper itself

Abstract

Found in the skins of red fruits, including grapes, resveratrol (RES) is a polyphenolic compound with cancer chemopreventive activity. Because of this activity, it has gained interest for scientific investigations. RES inhibits tumor growth and progression by targeting mitochondria-dependent or -independent pathways. However, further investigations are needed to explore the underlying mechanisms.The present study is focused on examining the role of RES-induced, mitochondria-mediated, caspase-independent apoptosis of prostate cancer cells, namely transgenic adenocarcinoma of mouse prostate (TRAMP) cells. These cells were exposed to RES for various times, and cell killing, cell morphology, mitochondrial membrane potential (Δψm), expression of Bax and Bcl2 proteins, the role of caspase-3, and DNA fragmentation were analyzed.TRAMP cells exposed to RES showed decreased cell viability, altered cell morphology, and disrupted Δψm, which led to aberrant expression of Bax and Bcl2 proteins. Furthermore, since the caspase-3 inhibitor, z-VAD-fmk (benzyloxycarbonyl-valine-alanine-aspartic acid-fluoromethyl ketone), had no appreciable impact on RES-induced cell killing, the killing was evidently caspase-independent. In addition, RES treatment of TRAMP-C1, TRAMP-C2, and TRAMP-C3 cells caused an appreciable breakage of genomic DNA into low-molecular-weight fragments.These findings show that, in inhibition of proliferation of TRAMP cells, RES induces mitochondria-mediated, caspase-independent apoptosis. Therefore, RES may be utilized as a therapeutic agent to control the proliferation and growth of cancer cells.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCaspase InhibitorsCaspasesCell Cycle ProteinsCell ProliferationHumansMaleMembrane Potential, MitochondrialMiceMitochondriaProstatic NeoplasmsResveratrolStilbenesTumor Cells, CulturedAntineoplastic Agents, PhytogenicCaspase InhibitorsCaspasesCell Cycle ProteinsResveratrolStilbenesapoptosismitochondriaprostate cancer cellsresveratrol

Identifiers

PMID28157696
PMCPMC5400554
OpenAlexW2585916169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.